We are live on ! Find out more
VCIM

Velan Capital Investment Management Portfolio holdings

AUM $160M
1-Year Est. Return 517.12%
This Fund
S&P 500
This Quarter Est. Return
+117.44%
1 Year Est. Return
+517.12%
3 Year Est. Return
+2,524.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$172M
AUM Growth
+$65.9M
Cap. Flow
+$15.6M
Cap. Flow %
9.03%
Top 10 Hldgs %
70.98%
Holding
57
New
8
Increased
5
Reduced
5
Closed
11

Top Buys

Rank Stock Value
1
EVMN
Evommune Inc
EVMN
+$9.52M
2
MPLT
MapLight Therapeutics
MPLT
+$8.75M
3
ESPR
Esperion Therapeutics
ESPR
+$3.91M
4
TARA icon
Protara Therapeutics
TARA
+$3.87M
5
VRCA icon
Verrica Pharmaceuticals
VRCA
+$2.61M

Top Sells

Rank Stock Value
1
PRAX icon
Praxis Precision Medicines
PRAX
+$5.96M
2
ZOOZ
ZOOZ Strategy Ltd
ZOOZ
+$4.28M
3
ALMS
Alumis Inc
ALMS
+$3.78M
4
QURE icon
uniQure
QURE
+$1.87M
5
TELA icon
TELA Bio
TELA
+$1.11M

Sector Composition

Rank Sector Weight
1 Healthcare 99.72%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GERN icon
51
Geron
GERN
$1.01B
– –
-80,000
Closed -$110K
QURE icon
52
uniQure
QURE
$3.13B
– –
-32,000
Closed -$1.87M
TELA icon
53
TELA Bio
TELA
$32.3M
– –
-747,410
Closed -$1.11M
TRML
54
DELISTED
Tourmaline Bio
TRML
– –
-5,800
Closed -$277K
WVE icon
55
Wave Life Sciences
WVE
$1.03B
– –
-15,000
Closed -$110K
ZOOZ
56
ZOOZ Strategy Ltd
ZOOZ
$42.9M
– –
-100,000
Closed -$4.28M
ALMS
57
Alumis Inc
ALMS
$3.26B
– –
-946,683
Closed -$3.78M
1 2
3

Similar funds

BFAG
Blackston Financial Advisory Group The Villages, Florida $160M AUM 16.38% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM
SMF
Sterling Manor Financial Saratoga Springs, New York $160M AUM 13.84% 1-Year Est. Return
LCA
Legend Capital Advisors New York $160M AUM
SGCM
Sanchez Gaunt Capital Management Reno, Nevada $160M AUM
RP
RIHO Partners Tucson, Arizona $159M AUM
PCC
Perry Creek Capital New York $160M AUM 3.05% 1-Year Est. Return
RCWM
Royal Capital Wealth Management Carmel, Indiana $161M AUM 18.42% 1-Year Est. Return

Velan Capital Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, Velan Capital Investment Management held 57 positions worth $172M, up 62% from $106M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Velan Capital Investment Management deployed $15.6M of net new capital in Q4 2025, opening 8 new positions and adding to 5 existing holdings. Its largest new stake was Evommune Inc: 506,754 shares worth $8.68M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 96% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Praxis Precision Medicines, an estimated $5.96M trimmed.

  • Velan Capital Investment Management's largest Q4 2025 buy was Evommune Inc: 506,754 shares worth $8.68M.
  • Velan Capital Investment Management added most to Protara Therapeutics in Q4 2025, an estimated $3.87M increase.
  • Velan Capital Investment Management's biggest Q4 2025 reduction was Praxis Precision Medicines, cutting an estimated $5.96M.
  • Velan Capital Investment Management fully exited ZOOZ Strategy Ltd in Q4 2025, selling an estimated $4.28M.
  • Velan Capital Investment Management's ten largest holdings make up 71% of its $172M portfolio in Q4 2025.
  • Velan Capital Investment Management opened 8 new positions and closed 11 in Q4 2025.
  • Velan Capital Investment Management's portfolio value rose 62% quarter-over-quarter to $172M.

Based on Velan Capital Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.